CLASS II Device recall · Reported 14 Oct 2020 · FDA Enforcement Report

Dimension Loci High Sensitivity Troponin I recalled

Siemens Healthcare Diagnostics is recalling Dimension Loci High Sensitivity Troponin I (Tnih) Flex reagent cartridge-Ivd-In vitro, distributed nationwide in the US. The recall was initiated on 19 Aug 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # EB0255 UDI: 00842768037726EB025520091110471068840
Quantity recalled533 US and 1822 OUS

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0052-2021
FDA event ID
86374
Recalling firm
Siemens Healthcare Diagnostics, Newark, DE
Classification
Class II
Status
Terminated
Recall initiated
19 Aug 2020
FDA classified
2 Oct 2020
Reported
14 Oct 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

19 Aug 2020Recall initiated by company
2 Oct 2020Classified by FDA+44 days
14 Oct 2020Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Positive bias across the Analytical Measurement Range of the TNIH assay compared to an unaffected control lot. The average bias observed for patient samples using lots EB0255 and EA0178 of the Dimension EXL Troponin compared with a control lot was +25%. A maximum bias of +34% in patient samples around the 99th percentile observed

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Dimension LOCI High Sensitivity Troponin I (TNIH) Flex reagent cartridge-IVD-In vitro diagnostic use in the quantitative measurement of cardiac troponin I in human plasma Catalog Number: RF627, SMN# 10471068

Where it was distributed

US Nationwide distribution.

Nationwide

Questions about this recall

Why was it recalled?

Positive bias across the Analytical Measurement Range of the TNIH assay compared to an unaffected control lot. The average bias observed for patient samples using lots EB0255 and EA0178 of the Dimension EXL Troponin compared with a control lot was +25%. A maximum bias of +34% in patient samples around the 99th percentile observed

Which lots are affected?

Lot # EB0255 UDI: 00842768037726EB025520091110471068840

Where was it sold?

US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Siemens Healthcare Diagnostics

All 694

Other Test Kits & Diagnostics recalls

All 2,656